Renalive LP

· Fresenius Kabi Taiwan Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Renalive LP, covering 2026-03-16 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: Suitability of Two Flavours of a High-energy, Low-protein Formula (Renalive® LP) in Chronic Kidney Disease Stage 3b-5 Outpatients in Taiwan [NA]

See pricing